248 related articles for article (PubMed ID: 23217327)
1. Cowchock syndrome is associated with a mutation in apoptosis-inducing factor.
Rinaldi C; Grunseich C; Sevrioukova IF; Schindler A; Horkayne-Szakaly I; Lamperti C; Landouré G; Kennerson ML; Burnett BG; Bönnemann C; Biesecker LG; Ghezzi D; Zeviani M; Fischbeck KH
Am J Hum Genet; 2012 Dec; 91(6):1095-102. PubMed ID: 23217327
[TBL] [Abstract][Full Text] [Related]
2. Whole-exome sequencing detected a novel AIFM1 variant in a Han-Chinese family with Cowchock syndrome.
Wang C; Lin Z; Yuan Z; Tang T; Fan L; Liu Y; Wu X
Hereditas; 2023 May; 160(1):22. PubMed ID: 37173762
[TBL] [Abstract][Full Text] [Related]
3. A novel AIFM1 mutation in a Chinese family with X-linked Charcot-Marie-Tooth disease type 4.
Wang B; Li X; Wang J; Liu L; Xie Y; Huang S; Pakhrin PS; Jin Q; Zhu C; Tang B; Niu Q; Zhang R
Neuromuscul Disord; 2018 Aug; 28(8):652-659. PubMed ID: 30031633
[TBL] [Abstract][Full Text] [Related]
4. Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor.
Ghezzi D; Sevrioukova I; Invernizzi F; Lamperti C; Mora M; D'Adamo P; Novara F; Zuffardi O; Uziel G; Zeviani M
Am J Hum Genet; 2010 Apr; 86(4):639-49. PubMed ID: 20362274
[TBL] [Abstract][Full Text] [Related]
5. A novel AIFM1 mutation expands the phenotype to an infantile motor neuron disease.
Diodato D; Tasca G; Verrigni D; D'Amico A; Rizza T; Tozzi G; Martinelli D; Verardo M; Invernizzi F; Nasca A; Bellacchio E; Ghezzi D; Piemonte F; Dionisi-Vici C; Carrozzo R; Bertini E
Eur J Hum Genet; 2016 Mar; 24(3):463-6. PubMed ID: 26173962
[TBL] [Abstract][Full Text] [Related]
6. A novel missense mutation in AIFM1 results in axonal polyneuropathy and misassembly of OXPHOS complexes.
Hu B; Wang M; Castoro R; Simmons M; Dortch R; Yawn R; Li J
Eur J Neurol; 2017 Dec; 24(12):1499-1506. PubMed ID: 28888069
[TBL] [Abstract][Full Text] [Related]
7. Spondyloepimetaphyseal dysplasia with neurodegeneration associated with AIFM1 mutation - a novel phenotype of the mitochondrial disease.
Mierzewska H; Rydzanicz M; Biegański T; Kosinska J; Mierzewska-Schmidt M; Ługowska A; Pollak A; Stawiński P; Walczak A; Kędra A; Obersztyn E; Szczepanik E; Płoski R
Clin Genet; 2017 Jan; 91(1):30-37. PubMed ID: 27102849
[TBL] [Abstract][Full Text] [Related]
8. Severe multisystem pathology, metabolic acidosis, mitochondrial dysfunction, and early death associated with an X-linked
Moss T; May M; Flanagan-Steet H; Caylor R; Jiang YH; McDonald M; Friez M; McConkie-Rosell A; Steet R
Cold Spring Harb Mol Case Stud; 2021 Jun; 7(3):. PubMed ID: 34117073
[TBL] [Abstract][Full Text] [Related]
9. Structure/Function Relations in AIFM1 Variants Associated with Neurodegenerative Disorders.
Sevrioukova IF
J Mol Biol; 2016 Sep; 428(18):3650-65. PubMed ID: 27178839
[TBL] [Abstract][Full Text] [Related]
10. Clinical spectrum of AIFM1-associated disease in an Irish family, from mild neuropathy to severe cerebellar ataxia with colour blindness.
Bogdanova-Mihaylova P; Alexander MD; Murphy RP; Chen H; Healy DG; Walsh RA; Murphy SM
J Peripher Nerv Syst; 2019 Dec; 24(4):348-353. PubMed ID: 31523922
[TBL] [Abstract][Full Text] [Related]
11. Deep Brain Stimulation for the Management of AIFM1-Related Disabling Tremor: A Case Series.
Tunyi J; Abreu NJ; Tripathi R; Mathew MT; Mears A; Agrawal P; Thakur V; Rezai AR; Reyes EL
Pediatr Neurol; 2023 May; 142():47-50. PubMed ID: 36907087
[TBL] [Abstract][Full Text] [Related]
12. From ventriculomegaly to severe muscular atrophy: expansion of the clinical spectrum related to mutations in AIFM1.
Kettwig M; Schubach M; Zimmermann FA; Klinge L; Mayr JA; Biskup S; Sperl W; Gärtner J; Huppke P
Mitochondrion; 2015 Mar; 21():12-8. PubMed ID: 25583628
[TBL] [Abstract][Full Text] [Related]
13.
Qiu Y; Wang H; Pan H; Guan J; Yan L; Fan M; Zhou H; Zhou X; Wu K; Jia Z; Zhuang Q; Lei Z; Li M; Ding X; Lin A; Fu Y; Zhang D; Wang Q; Yan Q
J Zhejiang Univ Sci B; 2023 Feb; 24(2):172-184. PubMed ID: 36751702
[TBL] [Abstract][Full Text] [Related]
14. AIF translocation into nucleus caused by Aifm1 R450Q mutation: generation and characterization of a mouse model for AUNX1.
Shi T; Chen Z; Li J; Wang H; Wang Q
Hum Mol Genet; 2024 May; 33(10):905-918. PubMed ID: 38449065
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis-inducing factor: structure, function, and redox regulation.
Sevrioukova IF
Antioxid Redox Signal; 2011 Jun; 14(12):2545-79. PubMed ID: 20868295
[TBL] [Abstract][Full Text] [Related]
16. The oxido-reductase activity of the apoptosis inducing factor: a promising pharmacological tool?
Ferreira P; Villanueva R; Cabon L; Susín SA; Medina M
Curr Pharm Des; 2013; 19(14):2628-36. PubMed ID: 23116400
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis-Inducing Factor (AIF) in Physiology and Disease: The Tale of a Repented Natural Born Killer.
Bano D; Prehn JHM
EBioMedicine; 2018 Apr; 30():29-37. PubMed ID: 29605508
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis-inducing Factor (AIF) and Its Family Member Protein, AMID, Are Rotenone-sensitive NADH:Ubiquinone Oxidoreductases (NDH-2).
Elguindy MM; Nakamaru-Ogiso E
J Biol Chem; 2015 Aug; 290(34):20815-20826. PubMed ID: 26063804
[TBL] [Abstract][Full Text] [Related]
19.
Morton SU; Prabhu SP; Lidov HGW; Shi J; Anselm I; Brownstein CA; Bainbridge MN; Beggs AH; Vargas SO; Agrawal PB
Cold Spring Harb Mol Case Stud; 2017 Mar; 3(2):a001560. PubMed ID: 28299359
[TBL] [Abstract][Full Text] [Related]
20. AIF: not just an apoptosis-inducing factor.
Joza N; Pospisilik JA; Hangen E; Hanada T; Modjtahedi N; Penninger JM; Kroemer G
Ann N Y Acad Sci; 2009 Aug; 1171():2-11. PubMed ID: 19723031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
